Olympus Corporation today announced that its Board of Directors named Michael C. Woodford to serve as the company’s president. Woodford will assume the office of President and Executive Officer on April 1, 2011, and upon the resolution passed at the annual shareholders meeting and the Board of Directors meeting set to be held on June […]
CHICAGO – Baird Venture Partners (BVP), the U.S.-based venture capital fund of Baird Private Equity, announced today that its portfolio company Accuri Cytometers (Accuri) has signed a definitive agreement to be acquired by Becton, Dickinson and Company (BD) (NYSE: BDX), a leading global medical technology company. The acquisition is subject to regulatory approvals and is […]
Fort Collins, CO, USA – InVitria announces that its Lysobac cell lysing reagent is manufactured at the Company’s Junction City, Kansas facility under cGMP (Current Good Manufacturing Practice) standards. Lysobac is a completely animal component free reagent that is substantially more effective and consistent than hen egg white lysozyme and complies with global regulatory standards […]
Walkersville, MD. – Lonza and California Stem Cell, Inc. are pleased to announce the first commercially available source of motor neuron progenitors derived from human embryonic stem cells. The MotorPlate™ Human ESC-derived Motor Neuron Progenitor products are functional, adherent motor neuron progenitors seeded in 96-well plates and shipped to customers fresh and ready-to-use with optimized […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it signed a definitive agreement to acquire Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and manufactures personal flow cytometers for researchers. The acquisition is subject to regulatory approvals and is expected to […]
MADISON, WISCONSIN – Promega Corporation and Fugent LLC recently signed a supply agreement that establishes Promega as a provider of the leading transfection tool FuGENE® 6. This agreement ensures that researchers will continue to have access to the FuGENE® transfection reagents they have always used in their daily research. This expands on the existing Promega/Fugent […]
BOULDER, CO – InDevR, one the West’s fastest growing biotechnology companies, today announced it has signed six agreements with leading life science instrument distributors for US and international territories to market the company’s ViroCyt™ 2100 Virus Counter®. The Virus Counter represents a significant technology shift that will dramatically streamline research and development efforts for vaccine […]
SAN DIEGO, CA – Cell Biolabs, Inc., a leader in life science products and research has introduced two new additions to its line of AAV Helper Free Systems: AAV-DJ and AAV-DJ/8. The first, AAV-DJ, was engineered via DNA family shuffling technology from 8 different native AAV serotypes to create a hybrid capsid. The resulting vector […]
Strasbourg – Polyplus-transfection SA, a privately-held company developing innovative solutions for the delivery of nucleic acids in research, bioproduction and therapy, announced today that it has granted Roche Glycart AG, a Swiss biotechnology company fully-owned by Roche, a non exclusive license to use polyethylenimine (PEI) for in vitro transfection applications for research purposes. By entering […]
New Milton, Hampshire, UK – Genetix today announced the launch of the new ClonePix™2 system – the second generation system based on the company’s well-established and successful technology and chemistries for clone screening and selection. The ClonePix 2 system utilizes fluorescence and white light imaging and advanced image analysis capabilities to automatically screen more clones […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
